...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Vote reminder

One week to the ZCC AGM.

This is your once in a year chance to express your opinion. At RVX Don's "withhold" was over 8%.

Let's make it 20%+ at ZCC.

JMHO

Toinv

1
Oct 21, 2023 11:04AM

Oct 22, 2023 10:41AM
4
Oct 22, 2023 04:03PM
3
Oct 23, 2023 11:05AM
4
Oct 23, 2023 06:16PM
5
Oct 24, 2023 10:07AM
3
Oct 24, 2023 10:22AM
Share
New Message
Please login to post a reply